Literature DB >> 10051298

Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy.

A Lazarus1, J Varin, Z Ounnoughene, H Radvanyi, C Junien, J Coste, P Laforet, B Eymard, H M Becane, S Weber, D Duboc.   

Abstract

BACKGROUND: Impulse-conduction abnormalities and arrhythmias are common in myotonic dystrophy (MD). This study was performed to determine whether a correlation exists between electrophysiological (EP) testing data and clinical status, heart function, or size of the DNA abnormality (cytosine-thymine-guanine sequence repeat). METHODS AND
RESULTS: Eighty-three MD patients underwent invasive EP studies prompted primarily by the presence of asymptomatic conduction abnormalities. AV conduction disturbances were common and mainly distal (HV interval, 66.2+/-14 ms). AV conduction observed from the surface ECG was generally concordant with endocardial measurements. However, 11 of 20 patients with normal surface ECGs had abnormal subhisian conduction. Atrial arrhythmias were inducible in 41% of cases and correlated with prolongation of the AH interval (P=0.02) and a shorter atrial refractory period (P=0.04). Induction of ventricular arrhythmias (18%) correlated strongly with age (P=0. 0003). After adjustment for age, the extent of DNA mutation correlated with the Walton score (P=0.0018) but not with conduction abnormalities or induction of arrhythmias.
CONCLUSIONS: Prolongation of the HV interval is the most common conduction abnormality in MD and can be reliably recognized only by invasive EP testing. It raises the issue of prophylactic pacing to limit the incidence of sudden death in MD. Atrial and ventricular arrhythmias are often inducible, although their predictive value remains to be determined. Young age emerged as the most powerful predictor of inducible ventricular tachyarrhythmias. Conversely, we found no relationship between ECG or EP abnormalities recorded during invasive testing and the DNA mutation size or severity of peripheral muscle involvement.

Entities:  

Mesh:

Year:  1999        PMID: 10051298     DOI: 10.1161/01.cir.99.8.1041

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 3.  [Cardiac manifestations of muscular dystrophies].

Authors:  A Perrot; S Spuler; C Geier; R Dietz; K J Osterziel
Journal:  Z Kardiol       Date:  2005-05

4.  Myotonia congenita and myotonic dystrophy: surveillance and management.

Authors:  Allison Conravey; Lenay Santana-Gould
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

5.  Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.

Authors:  Bradley A Hardin; Miriam R Lowe; Deepak Bhakta; William J Groh
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

6.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

7.  Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes.

Authors:  Nina D Ullrich; Mohammed Fanchaouy; Konstantin Gusev; Natalia Shirokova; Ernst Niggli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-25       Impact factor: 4.733

Review 8.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

9.  Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Authors:  F Rinaldi; A Botta; L Vallo; G Contino; A Morgante; R Iraci; C Catalli; G Silvestri; V M Ventriglia; L Politano; G Novelli
Journal:  Acta Myol       Date:  2008-12

Review 10.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.